| Title: |
Tucatinib–trastuzumab–capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results |
| Authors: |
Murthy, Rashmi K.Aff1, IDs43018026011207_cor1; O’Brien, Barbara J.Aff1; Berry, Donald A.Aff1; Singareeka-Raghavendra, AksharaAff1; Monroe, Maria GuleAff1; Johnson, JasonAff1; White, JasonAff1; Schwartz-Gomez, JillAff1; Topletz-Erickson, ArielAff2; Lobbous, MinaAff3; Riley, KristenAff3; Melisko, MichelleAff4; Morikawa, AkiAff5; Ferguson, Sherise D.Aff1; de Groot, John F.Aff1; Krop, Ian E.Aff6; Valero, VicenteAff1; Rimawi, Mothaffar F.Aff7; Wolff, Antonio C.Aff8; Tripathy, DebuAff1; Lin, Nancy U.Aff9; Stringer-Reasor, Erica M.Aff3 |
| Source: |
Nature Cancer. 7(3):424-434 |
| Database: |
Springer Nature Journals |